Canon's digital radiography CXDI-31 flat-panel sensor has passed FDA review, the company announced Jan. 22. The sensor will allow hospital technologists to image patients on
Canon's digital radiography CXDI-31 flat-panel sensor has passed FDA review, the company announced Jan. 22. The sensor will allow hospital technologists to image patients on stretchers, gurneys, and patient tables, capturing an image from virtually any angle. The amorphous silicon detector lists for $85,000. Clinical testing of the sensor, which weighs just 6.2 pounds and measures less than an inch thick, was completed at the Cleveland Clinic Foundation clinical radiology and neonatal ICU departments. CXDI-31 is the latest addition to the company's DR products, whose first member, the CXDI-11 digital radiography system (upright), was launched in 1998. The CXDI-22 (digital bucky) joined the family in 2000. These Canon-developed systems are used in more than 350 locations worldwide.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.